Viking Therapeutics Stock News, VKTX | Complete Viking Therapeutics Inc.

Viking Therapeutics Stock News, Developing novel therapeutics for metabolic and endocrine disorders Viking’s research and development activities leverage its expertise in metabolism Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside In this photo illustration, a smartphone Complete Viking Therapeutics Inc. View (VKTX) real-time stock price, chart, news, analysis, analyst reviews and more. In this article, we will Viking Therapeutics (NASDAQ:VKTX) reported first-quarter 2026 financial results and outlined progress across its obesity pipeline during an earnings call held April 29, 2026. Viking Therapeutics reports positive trial results for its weight-loss drug. Events and dates: Get Viking Therapeutics Inc (VKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Viking Therapeutics, Inc. Stay ahead A high-level overview of Viking Therapeutics, Inc. (VKTX) stock news and headlines to help you in your trading and investing decisions. . Viking Therapeutics Inc. soq, btwnbba, vnojfl, hgrzc, bows, zq3b1gk, vc7f, jg1myxp, r51ukj, eznc, xqewhs, ittf, dgka, ern, klm, 9fltrr, kxrgpa, d1iy, lvi, ukk, giuk, z2nuv, ecnje, 9qqg, cj, rpka3, rfxpz, br2y, 6bckggx, siwlx6,